CIK: 1499254 - Address: C/o Anixa Biosciences, Inc., 3150 Almaden Expressway, Suite 250, San Jose,, CA 95118
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/14/24 09:56
6/13/24
ANIXAnixa Biosciences IncDEHealthDrugPharmaceutical PreparationsTitterton Lewis H JrCADP12.70000857D
6/12/24 11:18
6/10/24
ANIXAnixa Biosciences IncDEHealthDrugPharmaceutical PreparationsTitterton Lewis H JrCADP.m202.66071856D
6/10/24 10:03
6/7/24
ANIXAnixa Biosciences IncDEHealthDrugPharmaceutical PreparationsTitterton Lewis H JrCADP272.520111849D
4/10/24 09:44
4/9/24
ANIXAnixa Biosciences IncDEHealthDrugPharmaceutical PreparationsTitterton Lewis H JrCADP493.280152838D
4/27/22 10:01
4/26/22
ANIXAnixa Biosciences IncDEHealthDrugPharmaceutical PreparationsTitterton Lewis H JrCADP282.790101988D
1/13/22 10:23
1/12/22
ANIXAnixa Biosciences IncDEHealthDrugPharmaceutical PreparationsTitterton Lewis H JrCADP163.28051978D
1/12/22 09:54
1/11/22
ANIXAnixa Biosciences IncDEHealthDrugPharmaceutical PreparationsTitterton Lewis H JrCADP63.20020973D
1/11/22 09:21
1/10/22
ANIXAnixa Biosciences IncDEHealthDrugPharmaceutical PreparationsTitterton Lewis H JrCADP183.08061971D
1/10/22 09:36
1/7/22
ANIXAnixa Biosciences IncDEHealthDrugPharmaceutical PreparationsTitterton Lewis H JrCADP343.080111965D
11/1/21 13:32
10/29/21
ANIXAnixa Biosciences IncDEHealthDrugPharmaceutical PreparationsTitterton Lewis H JrCADP874.760182954D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact